VisionPoint Advisory Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-205
Closed -$19.9K 335
2024
Q2
$19.9K Sell
205
-90
-31% -$8.3K 0.01% 389
2024
Q1
$26.6K Sell
295
-15
-5% -$1.27K 0.01% 354
2023
Q4
$24.7K Sell
310
-1
-0.3% -$75 0.01% 337
2023
Q3
$22.1K Buy
+311
New +$23.3K 0.01% 360
2020
Q1
Sell
-32,875
Closed -$2.26M 122
2019
Q4
$2.26M Buy
32,875
+2,541
+8% +$173K 0.94% 28
2019
Q3
$2.19M Buy
30,334
+2,274
+8% +$165K 0.6% 29
2019
Q2
$2.01M Buy
28,060
+1,498
+6% +$106K 0.58% 29
2019
Q1
$1.82M Buy
+26,562
New +$1.72M 0.51% 33

Other funds holding CL

VisionPoint Advisory Group's CL Position: Q3 2024 in Review

VisionPoint Advisory Group sold out of Colgate-Palmolive (CL) in Q3 2024, closing a stake of 205 shares — an estimated $19.9K sold.

VisionPoint Advisory Group first reported a position in CL in Q1 2019 and held it in 8 quarters. The position peaked at $2.26M in Q4 2019. 1,909 funds tracked by Wall St. Rank hold CL as of Q3 2024.

  • VisionPoint Advisory Group reported no remaining Colgate-Palmolive position as of Q3 2024 after selling out during the quarter.
  • VisionPoint Advisory Group sold 205 Colgate-Palmolive shares in Q3 2024, an estimated $19.9K.
  • VisionPoint Advisory Group first reported a position in Colgate-Palmolive in Q1 2019 and held it in 8 quarters.
  • VisionPoint Advisory Group's Colgate-Palmolive position peaked at $2.26M in Q4 2019.
  • 1,909 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on VisionPoint Advisory Group's 13F filing for Q3 2024, filed 15 Oct 2024.